These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1664756)

  • 1. The production of group O cells.
    Lenny LL; Goldstein J
    Biotechnology; 1991; 19():75-100. PubMed ID: 1664756
    [No Abstract]   [Full Text] [Related]  

  • 2. Universal red blood cells--enzymatic conversion of blood group A and B antigens.
    Olsson ML; Hill CA; de la Vega H; Liu QP; Stroud MR; Valdinocci J; Moon S; Clausen H; Kruskall MS
    Transfus Clin Biol; 2004 Feb; 11(1):33-9. PubMed ID: 14980547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preparation of transfusable human universal red blood cell with recombinant alpha-galactosidase].
    Gong F; Lü QS; You Y; Gao HW; Bao GQ; Gao X; Li SB; Li LL; Wang YL; Tian SG; Zhang ZX; Zhang P; Zhang YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):313-6. PubMed ID: 15854299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deantigenation of human type B erythrocytes with Glycine max alpha-D-galactosidase.
    Hobbs L; Mitra M; Phillips R; Haibach H; Smith D
    Biomed Pharmacother; 1995; 49(5):244-50. PubMed ID: 7579003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group B erythrocytes enzymatically converted to group O survive normally in A, B, and O individuals.
    Goldstein J; Siviglia G; Hurst R; Lenny L; Reich L
    Science; 1982 Jan; 215(4529):168-70. PubMed ID: 6274021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards universally acceptable blood.
    Clausen H; Olsson ML
    Nat Microbiol; 2019 Sep; 4(9):1426-1427. PubMed ID: 31439931
    [No Abstract]   [Full Text] [Related]  

  • 7. B to O erythrocyte conversion by the recombinant alpha-galactosidase.
    Zhang YP; Gong F; Bao GQ; Gao HW; Ji SP; Tan YX; Li SB; Li LL; Wang YL; Xu H; Xu LJ; Tian SG; Zhang ZX; Lü QS; Qiu Y; Bai JS; Chen JT
    Chin Med J (Engl); 2007 Jul; 120(13):1145-50. PubMed ID: 17637242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designer red cells.
    Wilson RB; Spitalnik SL
    Transfusion; 1994 Mar; 34(3):189-91. PubMed ID: 8146889
    [No Abstract]   [Full Text] [Related]  

  • 9. Cloning, sequence, and expression of a blood group B active recombinant alpha-D-galactosidase from pinto bean (Phaseolus vulgaris).
    Davis MO; Hata DJ; Johnson SA; Jones DE; Harmata MA; Evans ML; Walker JC; Smith DS
    Biochem Mol Biol Int; 1997 Jul; 42(3):453-67. PubMed ID: 9247703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative strategy for overcoming ABO incompatibility.
    Kobayashi T; Liu D; Ogawa H; Miwa Y; Nagasaka T; Maruyama S; Li YT; Onishi A; Kuzuya T; Kadomatsu K; Uchida K; Nakao A
    Transplantation; 2007 May; 83(9):1284-6. PubMed ID: 17496551
    [No Abstract]   [Full Text] [Related]  

  • 11. Action of alpha-galactosidase from Clostridium sporogenes and coffee beans on blood group B antigen of erythrocytes. The effect on the viability of erythrocytes in circulation.
    Dybus S; Aminoff D
    Transfusion; 1983; 23(3):244-7. PubMed ID: 6304953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosidases in structural analysis.
    Jacob GS; Scudder P
    Methods Enzymol; 1994; 230():280-99. PubMed ID: 8139502
    [No Abstract]   [Full Text] [Related]  

  • 13. Cloning and genetic characterization of blood group carrier molecules and antigens.
    Lögdberg L; Reid ME; Miller JL
    Transfus Med Rev; 2002 Jan; 16(1):1-10. PubMed ID: 11788925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Green coffee beans may solve a blood bank problem.
    Cowart VS
    JAMA; 1982 Jan; 247(1):12. PubMed ID: 6273606
    [No Abstract]   [Full Text] [Related]  

  • 15. Primate animal model for the study of ABO incompatibility in organ transplantation.
    Socha WW; Marboe CC; Michler RE; Rose EA; Moor-Jankowski J
    Transplant Proc; 1987 Dec; 19(6):4448-55. PubMed ID: 3424439
    [No Abstract]   [Full Text] [Related]  

  • 16. Mucin-type fusion proteins with blood group A or B determinants on defined O-glycan core chains produced in glycoengineered Chinese hamster ovary cells and their use as immunoaffinity matrices.
    Lindberg L; Liu J; Gaunitz S; Nilsson A; Johansson T; Karlsson NG; Holgersson J
    Glycobiology; 2013 Jun; 23(6):720-35. PubMed ID: 23424082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terminology for red cell surface antigens. ISBT Working Party Oslo Report. International Society of Blood Transfusion.
    Daniels GL; Anstee DJ; Cartron JP; Dahr W; Garratty G; Henry S; Jørgensen J; Judd WJ; Kornstad L; Levene C; Lomas-Francis C; Lubenko A; Moulds JJ; Moulds JM; Moulds M; Overbeeke M; Reid ME; Rouger P; Scott M; Seidl S; Sistonen P; Tani Y; Wendel S; Zelinski T
    Vox Sang; 1999; 77(1):52-7. PubMed ID: 10474091
    [No Abstract]   [Full Text] [Related]  

  • 18. The emerging role of ABH blood group antigens as modulators of cell membrane function.
    Engelmann B; Schumacher U
    Comp Biochem Physiol Comp Physiol; 1993 Jun; 105(2):197-203. PubMed ID: 8101151
    [No Abstract]   [Full Text] [Related]  

  • 19. Modifying the red cell surface: towards an ABO-universal blood supply.
    Olsson ML; Clausen H
    Br J Haematol; 2008 Jan; 140(1):3-12. PubMed ID: 17970801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation, characterization, and properties of Saccharomyces cerevisiae mnn mutants with nonconditional protein glycosylation defects.
    Ballou CE
    Methods Enzymol; 1990; 185():440-70. PubMed ID: 2199792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.